Title:
NOVEL ANTI-PD-L1 CHIMERIC ANTIGEN RECEPTOR, AND IMMUNE CELLS EXPRESSING SAME
Document Type and Number:
WIPO Patent Application WO/2024/049161
Kind Code:
A1
Abstract:
The present invention relates to a novel antibody or an antigen-binding fragment thereof, which specifically binds to PD-L1, a chimeric antigen receptor comprising an antigen-binding variable fragment of the antibody, immune cells expressing the chimeric antigen receptor, and a pharmaceutical composition for treating or preventing cancer, the pharmaceutical composition comprising the immune cells.
Inventors:
KIM TAE-DON (KR)
LEE SOOYUN (KR)
LEE SOOYUN (KR)
Application Number:
PCT/KR2023/012785
Publication Date:
March 07, 2024
Filing Date:
August 29, 2023
Export Citation:
Assignee:
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR)
International Classes:
C07K16/28; A61K35/17; A61P35/00; C07K14/725
Foreign References:
| KR20170135860A | 2017-12-08 | |||
| JP2021524478A | 2021-09-13 | |||
| KR20200104886A | 2020-09-04 | |||
| KR20200119891A | 2020-10-20 | |||
| US20190169296A1 | 2019-06-06 | |||
| KR102534281B1 | 2023-05-30 |
Attorney, Agent or Firm:
BAE, KIM & LEE IP (KR)
Download PDF: